The WuXi agreement gives Fresenius "full strategic flexibility" to choose which biosimilar candidates to develop and gives ...
Dojolvi was approved in the US in 2020 and was also launched in Japan earlier this year. Ultragenyx recorded sales of $45 ...
Hutchmed and AstraZeneca's Orpathys is now under review in Europe and Japan for MET-driven, EGFR-mutated lung cancer, a few ...
Voceryq (doruxapapogene ralaplasmid and lalikinogene sifuplasmid) has been granted an accelerated approval by the FDA as a ...
As the only dedicated forum convening the global liquid biopsy community, the 11th Liquid Biopsy for Precision Oncology ...
On 3 and 4 December 2026, Florence will host ISMAI 2026, the International Symposium on Medical AI, organised by the ...
A patient-led initiative for rare disease hereditary haemorrhagic telangiectasia (HHT) has won the inaugural Prix Galien ...
Evolution Summit 2027 to Convene Senior Clinical Development Leaders in Westlake Village, California
Marcus Evans today announced the Evolution Summit 2027, an invitation-only gathering of senior clinical trial executives, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results